SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-015807
Filing Date
2020-04-08
Accepted
2020-04-08 07:30:17
Documents
1
Period of Report
2020-04-08
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K agle-8k_20200408.htm 8-K 61320
  Complete submission text file 0001564590-20-015807.txt   62375
Mailing Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746
Business Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37722 | Film No.: 20781098
SIC: 2834 Pharmaceutical Preparations